Lance E. Thibault

Insider Reports History

Latest reporting-owner signature: /s/ Matthew P. Blischak, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Insider Reports Filed by Lance E. Thibault

3 FNCH

Finch Therapeutics Group, Inc.

Report period: 16 May 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 16 May 2023, 16:05
Role: Chief Financial Officer
Next action: Open filing details

3 ACLX

Arcellx, Inc.

Report period: 03 Feb 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 03 Feb 2022, 16:22
Role: Interim Chief Financial Officer Exhibit 24 - Power of Attorney
Next action: Open filing details

3 WHWK

Aadi Bioscience, Inc.

Report period: 26 Aug 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 31 Aug 2021, 20:14
Role: Chief Financial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .